Form 8-K - Current report:
SEC Accession No. 0001477932-22-001199
Filing Date
2022-03-04
Accepted
2022-03-04 16:23:25
Documents
2
Period of Report
2022-01-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm 8-K 26642
2 LETTER thct_ex161.htm EX-16.1 4938
  Complete submission text file 0001477932-22-001199.txt   32961
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0729
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 22714379
SIC: 3523 Farm Machinery & Equipment